{"gene":"POLE3","run_date":"2026-04-28T19:45:44","timeline":{"discoveries":[{"year":2000,"finding":"POLE3 (CHRAC17) and POLE4 (CHRAC15) are two novel histone-fold proteins present in the human CHRAC (HuCHRAC) chromatin-remodeling complex alongside hACF1 and SNF2H (ISWI). The two histone-fold proteins form a stable sub-complex that binds naked DNA but not nucleosomes.","method":"Biochemical purification of HuCHRAC, identification of subunits, in vitro DNA-binding assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — direct biochemical purification and characterization of complex with functional binding assays","pmids":["10880450"],"is_preprint":false},{"year":2002,"finding":"The ACF1-ISWI chromatin-remodeling complex (which contains POLE3/CHRAC17 and POLE4/CHRAC15 as subunits) is specifically required for DNA replication through pericentromeric heterochromatin; RNAi depletion of ACF1 impairs late-S-phase replication of heterochromatic regions.","method":"RNAi depletion, BrdU incorporation, cell-cycle analysis, immunofluorescence showing enrichment at replicating heterochromatin","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 — functional KD with specific heterochromatin replication phenotype, orthogonal methods","pmids":["12434153"],"is_preprint":false},{"year":2008,"finding":"POLE3 (CHRAC17) and POLE4 are components of the human ATAC acetyltransferase complex, associating with GCN5/PCAF acetyltransferases and other chromatin-regulatory factors, linking the POLE complex subunits to transcriptional regulation in addition to DNA replication.","method":"Biochemical purification of human ATAC complex followed by mass spectrometry and co-immunoprecipitation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — direct purification of complex with mass spectrometry and reciprocal co-IP validation","pmids":["18838386"],"is_preprint":false},{"year":2010,"finding":"The CHRAC complex (containing ACF1, SNF2H, CHRAC15/POLE4, and CHRAC17/POLE3) accumulates rapidly at DNA double-strand breaks (DSBs) and is required for DSB repair via both NHEJ and HR. ACF1 interacts directly with KU70 and is required for KU70/80 accumulation at DSBs; depletion of ACF1 or SNF2H causes extreme sensitivity to DSB-inducing agents and failure to repair DSBs.","method":"Live-cell imaging of GFP-tagged subunits at laser-induced DSBs, co-immunoprecipitation, RNAi depletion, clonogenic survival, DSB repair reporter assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (live imaging, co-IP, KD + functional readouts) in a single study","pmids":["21172662"],"is_preprint":false},{"year":2018,"finding":"The POLE3-POLE4 subcomplex of DNA polymerase epsilon selectively binds histones H3-H4 (not H2A-H2B) through defined minimal domains identified by hydrogen/deuterium exchange mass spectrometry. POLE3-POLE4 acts as a bona fide histone chaperone, promoting tetrasome formation and DNA supercoiling in vitro. In cells, POLE3-POLE4 associates with both newly synthesized and parental histones; its depletion impairs replication fork helicase unwinding, delays chromatin PCNA unloading, and disrupts coordinated parental histone retention and new histone deposition, demonstrating a role in replication-coupled nucleosome assembly.","method":"Hydrogen/deuterium exchange mass spectrometry, pulldown/co-IP mapping of interaction domains, in vitro tetrasome formation and DNA supercoiling assays, iPOND (isolation of proteins on nascent DNA), flow cytometry, proximity ligation assay","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 — reconstituted histone chaperone activity in vitro plus multiple orthogonal cellular assays; single rigorous study with strong mechanistic resolution","pmids":["30217558"],"is_preprint":false},{"year":2020,"finding":"In mice, Pole3 is dispensable for bulk DNA replication (null mice survive to late embryonic stages) but is required in a stage-specific manner during T and B lymphocyte development. The histone fold domain of POLE3 mediates this lymphocyte-specific function. Progressive introduction of positively charged residues into the normally acidic C-terminus of POLE3 causes increasingly severe peripheral lymphopenia, revealing that the acidic C-terminus is functionally critical for lymphocyte homeostasis.","method":"Mouse knockout and hypomorphic/neomorphic allele generation, flow cytometric analysis of lymphocyte development stages, domain-specific mutagenesis of the acidic C-terminus","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — multiple defined alleles with graded phenotypic consequences, clean developmental stage mapping","pmids":["32553171"],"is_preprint":false}],"current_model":"POLE3, together with its obligate partner POLE4, forms a histone H3-H4 chaperone subcomplex within the DNA polymerase epsilon holoenzyme that promotes tetrasome formation and replication-coupled nucleosome assembly at the replication fork; it is also a structural component of the CHRAC chromatin-remodeling complex (with ACF1/SNF2H) required for heterochromatin replication and DNA double-strand break repair, and participates in the ATAC acetyltransferase complex, while its histone fold domain and acidic C-terminus confer non-replicative, lymphocyte-specific functions during T and B cell development in vivo."},"narrative":{"teleology":[{"year":2000,"claim":"Identification of POLE3 as a histone-fold subunit of the CHRAC chromatin-remodeling complex established that this small protein participates in chromatin architecture beyond its association with DNA polymerase epsilon.","evidence":"Biochemical purification of HuCHRAC and in vitro DNA-binding assays showing POLE3–POLE4 heterodimer binds naked DNA","pmids":["10880450"],"confidence":"High","gaps":["Whether the POLE3–POLE4 DNA-binding activity is functionally required within CHRAC was not resolved","No information on POLE3 function independent of the CHRAC complex"]},{"year":2002,"claim":"Demonstrating that the ACF1–ISWI/CHRAC complex is specifically needed for heterochromatin replication in late S-phase placed POLE3 in the context of replication through difficult chromatin templates.","evidence":"RNAi depletion of ACF1 combined with BrdU incorporation, cell-cycle analysis, and immunofluorescence in human cells","pmids":["12434153"],"confidence":"High","gaps":["POLE3 was not individually depleted; phenotype attributed to the whole CHRAC/ACF complex","Mechanism by which CHRAC facilitates heterochromatin replication (remodeling vs. histone chaperoning) was unresolved"]},{"year":2008,"claim":"Finding POLE3 and POLE4 within the ATAC acetyltransferase complex expanded their functional repertoire to transcriptional regulation via histone acetylation.","evidence":"Biochemical purification of the human ATAC complex with mass spectrometry and reciprocal co-immunoprecipitation","pmids":["18838386"],"confidence":"High","gaps":["Functional contribution of POLE3–POLE4 within the ATAC complex was not tested","Whether POLE3 participates in ATAC and Pol epsilon simultaneously or in mutually exclusive pools was unknown"]},{"year":2010,"claim":"Showing that the CHRAC complex rapidly accumulates at DNA double-strand breaks and is required for both NHEJ and HR revealed a DNA repair function for POLE3-containing chromatin remodeling machinery.","evidence":"Live-cell imaging of GFP-tagged subunits at laser-induced DSBs, co-immunoprecipitation with KU70, RNAi depletion combined with clonogenic survival and DSB repair reporter assays","pmids":["21172662"],"confidence":"High","gaps":["Direct requirement for POLE3 specifically (as opposed to other CHRAC subunits) at DSBs was not isolated","Whether the histone-fold DNA-binding activity of POLE3–POLE4 contributes to CHRAC recruitment at DSBs was untested"]},{"year":2018,"claim":"Reconstituting POLE3–POLE4 as a bona fide H3–H4 histone chaperone that promotes tetrasome assembly resolved the long-standing question of how the Pol epsilon holoenzyme participates in replication-coupled nucleosome assembly.","evidence":"HDX-MS domain mapping, in vitro tetrasome and supercoiling assays, iPOND, flow cytometry, and proximity ligation assay in human cells","pmids":["30217558"],"confidence":"High","gaps":["Structural basis of H3–H4 recognition by the POLE3–POLE4 heterodimer at atomic resolution was not determined","Relative contributions of POLE3–POLE4 vs. other chaperones (e.g., CAF-1, ASF1) at the fork were not quantified"]},{"year":2020,"claim":"Mouse genetics demonstrated that POLE3 is dispensable for bulk DNA replication but essential for lymphocyte development, establishing a non-replicative, tissue-specific function mediated by its histone fold and acidic C-terminus.","evidence":"Pole3 knockout and charge-reversal allele series in mice with flow cytometric staging of T and B cell development","pmids":["32553171"],"confidence":"High","gaps":["Molecular mechanism linking POLE3 histone-fold and acidic tail to lymphocyte-specific chromatin regulation is unknown","Whether the lymphocyte phenotype reflects disrupted histone chaperoning, CHRAC function, ATAC activity, or a distinct interaction is unresolved"]},{"year":null,"claim":"An atomic-resolution structure of POLE3–POLE4 bound to H3–H4 is lacking, and the mechanistic basis of the lymphocyte-specific requirement remains uncharacterized.","evidence":"","pmids":[],"confidence":"High","gaps":["No high-resolution structure of the POLE3–POLE4–H3–H4 complex","Functional partitioning of POLE3 among Pol epsilon, CHRAC, and ATAC pools in vivo is undetermined","Molecular basis of the tissue-specific (lymphocyte) requirement for POLE3 is unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[4]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0]}],"localization":[{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[1,4]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,3]}],"pathway":[{"term_id":"R-HSA-69306","term_label":"DNA Replication","supporting_discovery_ids":[1,4]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[0,4]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[3]}],"complexes":["DNA polymerase epsilon","CHRAC","ATAC"],"partners":["POLE4","ACF1","SNF2H","KU70"],"other_free_text":[]},"mechanistic_narrative":"POLE3 is a histone-fold protein that, together with its obligate partner POLE4, serves as a histone H3–H4 chaperone subcomplex within the DNA polymerase epsilon holoenzyme, promoting tetrasome formation and replication-coupled nucleosome assembly at the replication fork [PMID:30217558]. Beyond its replicative role, POLE3 is a structural subunit of the CHRAC chromatin-remodeling complex (with ACF1 and SNF2H), which is required for heterochromatin replication in late S-phase and for DNA double-strand break repair via both NHEJ and HR [PMID:10880450, PMID:12434153, PMID:21172662], and is also a component of the ATAC acetyltransferase complex [PMID:18838386]. In mice, Pole3 is dispensable for bulk DNA replication but is specifically required during T and B lymphocyte development, where its histone fold domain and acidic C-terminus are functionally critical for lymphocyte homeostasis [PMID:32553171]."},"prefetch_data":{"uniprot":{"accession":"Q9NRF9","full_name":"DNA polymerase epsilon subunit 3","aliases":["Arsenic-transactivated protein","AsTP","Chromatin accessibility complex 17 kDa protein","CHRAC-17","HuCHRAC17","DNA polymerase II subunit 3","DNA polymerase epsilon subunit p17"],"length_aa":147,"mass_kda":16.9,"function":"Accessory component of the DNA polymerase epsilon complex (PubMed:10801849). Participates in DNA repair and in chromosomal DNA replication (By similarity). Forms a complex with CHRAC1 and binds naked DNA, which is then incorporated into chromatin, aided by the nucleosome-remodeling activity of ISWI/SNF2H and ACF1 (PubMed:10801849). Does not enhance nucleosome sliding activity of the ACF-5 ISWI chromatin remodeling complex (PubMed:14759371)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9NRF9/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/POLE3","classification":"Not Classified","n_dependent_lines":397,"n_total_lines":1208,"dependency_fraction":0.32864238410596025},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"SMARCA1","stoichiometry":4.0},{"gene":"SMARCA5","stoichiometry":4.0},{"gene":"HIST2H2BE","stoichiometry":0.2},{"gene":"HMGA1","stoichiometry":0.2},{"gene":"NUCKS1","stoichiometry":0.2},{"gene":"SCYL2","stoichiometry":0.2},{"gene":"SSRP1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/POLE3","total_profiled":1310},"omim":[{"mim_id":"613373","title":"YEATS DOMAIN-CONTAINING PROTEIN 2; YEATS2","url":"https://www.omim.org/entry/613373"},{"mim_id":"607269","title":"POLYMERASE, DNA, EPSILON-4; POLE4","url":"https://www.omim.org/entry/607269"},{"mim_id":"607268","title":"CHROMATIN ACCESSIBILITY COMPLEX, SUBUNIT 1; CHRAC1","url":"https://www.omim.org/entry/607268"},{"mim_id":"607267","title":"POLYMERASE, DNA, EPSILON-3; POLE3","url":"https://www.omim.org/entry/607267"},{"mim_id":"605680","title":"BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN, 1A; BAZ1A","url":"https://www.omim.org/entry/605680"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Nucleoli","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/POLE3"},"hgnc":{"alias_symbol":["CHRAC17","Ybl1","p17","CHARAC17","CHRAC2"],"prev_symbol":[]},"alphafold":{"accession":"Q9NRF9","domains":[{"cath_id":"1.10.20.10","chopping":"1-77","consensus_level":"medium","plddt":92.6501,"start":1,"end":77},{"cath_id":"1.20.5","chopping":"94-147","consensus_level":"medium","plddt":71.662,"start":94,"end":147}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NRF9","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NRF9-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NRF9-F1-predicted_aligned_error_v6.png","plddt_mean":86.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=POLE3","jax_strain_url":"https://www.jax.org/strain/search?query=POLE3"},"sequence":{"accession":"Q9NRF9","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NRF9.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NRF9/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NRF9"}},"corpus_meta":[{"pmid":"9148968","id":"PMC_9148968","title":"A sequential two-step mechanism for the production of the mature p17:p12 form of caspase-3 in vitro.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9148968","citation_count":214,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8065455","id":"PMC_8065455","title":"Structural similarity between the p17 matrix protein of HIV-1 and interferon-gamma.","date":"1994","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8065455","citation_count":130,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2462060","id":"PMC_2462060","title":"Human immunodeficiency virus type 1-neutralizing monoclonal antibodies which react with p17 core protein: characterization and epitope mapping.","date":"1989","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/2462060","citation_count":115,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30217558","id":"PMC_30217558","title":"POLE3-POLE4 Is a Histone H3-H4 Chaperone that Maintains Chromatin Integrity during DNA Replication.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/30217558","citation_count":111,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1744586","id":"PMC_1744586","title":"Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities.","date":"1991","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/1744586","citation_count":106,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3126756","id":"PMC_3126756","title":"Decline of antibody reactivity to outer viral core protein p17 is an earlier serological marker of disease progression in human immunodeficiency virus infection than anti-p24 decline.","date":"1987","source":"AIDS (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/3126756","citation_count":98,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22904195","id":"PMC_22904195","title":"HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22904195","citation_count":81,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2437588","id":"PMC_2437588","title":"Human immunodeficiency virus contains an epitope immunoreactive with thymosin alpha 1 and the 30-amino acid synthetic p17 group-specific antigen peptide HGP-30.","date":"1987","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2437588","citation_count":79,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9094619","id":"PMC_9094619","title":"Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17.","date":"1997","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/9094619","citation_count":72,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1698289","id":"PMC_1698289","title":"HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals.","date":"1990","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1698289","citation_count":72,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1548487","id":"PMC_1548487","title":"Increased phosphorylation of a 17-kDa protein kinase C substrate (P17) in long-term potentiation.","date":"1992","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1548487","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26578780","id":"PMC_26578780","title":"Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26578780","citation_count":65,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9696871","id":"PMC_9696871","title":"Detection of a trimeric human immunodeficiency virus type 1 Gag intermediate is dependent on sequences in the matrix protein, p17.","date":"1998","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/9696871","citation_count":65,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16608119","id":"PMC_16608119","title":"Functions of the HIV-1 matrix protein p17.","date":"2006","source":"The new microbiologica","url":"https://pubmed.ncbi.nlm.nih.gov/16608119","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21423810","id":"PMC_21423810","title":"Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21423810","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16143310","id":"PMC_16143310","title":"Retardation of cell growth by avian reovirus p17 through the activation of p53 pathway.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16143310","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20504920","id":"PMC_20504920","title":"African swine fever virus protein p17 is essential for the progression of viral membrane precursors toward icosahedral intermediates.","date":"2010","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/20504920","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23072732","id":"PMC_23072732","title":"Sequences within RNA coding for HIV-1 Gag p17 are efficiently targeted to exosomes.","date":"2012","source":"Cellular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/23072732","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31535025","id":"PMC_31535025","title":"Mitochondrial protein import is regulated by p17/PERMIT to mediate lipid metabolism and cellular stress.","date":"2019","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/31535025","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18310327","id":"PMC_18310327","title":"HIV-1 matrix protein p17 induces human plasmacytoid dendritic cells to acquire a migratory immature cell phenotype.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18310327","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8267904","id":"PMC_8267904","title":"Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.","date":"1993","source":"AIDS (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/8267904","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1667575","id":"PMC_1667575","title":"Immunodiagnosis of feline immunodeficiency virus infection using recombinant viral p17 and p24.","date":"1991","source":"AIDS (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/1667575","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7851008","id":"PMC_7851008","title":"The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression.","date":"1995","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/7851008","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7769715","id":"PMC_7769715","title":"A molecular determinant of human immunodeficiency virus particle assembly located in matrix antigen p17.","date":"1995","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/7769715","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15280532","id":"PMC_15280532","title":"Total chemical synthesis of N-myristoylated HIV-1 matrix protein p17: structural and mechanistic implications of p17 myristoylation.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15280532","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33374251","id":"PMC_33374251","title":"African Swine Fever Virus Structural Protein p17 Inhibits Cell Proliferation through ER Stress-ROS Mediated Cell Cycle Arrest.","date":"2020","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/33374251","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18042260","id":"PMC_18042260","title":"HIV-1 matrix protein p17 binds to monocytes and selectively stimulates MCP-1 secretion: role of transcriptional factor AP-1.","date":"2007","source":"Cellular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/18042260","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24482377","id":"PMC_24482377","title":"HIV-1 matrix protein p17 promotes lymphangiogenesis and activates the endothelin-1/endothelin B receptor axis.","date":"2014","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/24482377","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35844609","id":"PMC_35844609","title":"African Swine Fever Virus Structural Protein p17 Inhibits cGAS-STING Signaling Pathway Through Interacting With STING.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35844609","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2187072","id":"PMC_2187072","title":"Analysis of the secondary structure of the human immunodeficiency virus (HIV) proteins p17, gp120, and gp41 by computer modeling based on neural network methods.","date":"1990","source":"Journal of acquired immune deficiency syndromes","url":"https://pubmed.ncbi.nlm.nih.gov/2187072","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20816696","id":"PMC_20816696","title":"HIV-1 matrix protein p17: a candidate antigen for therapeutic vaccines against AIDS.","date":"2010","source":"Pharmacology & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/20816696","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9085253","id":"PMC_9085253","title":"Inhibition of early and late events of the HIV-1 replication cycle by cytoplasmic Fab intrabodies against the matrix protein, p17.","date":"1997","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/9085253","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27603133","id":"PMC_27603133","title":"Suppression of Vimentin Phosphorylation by the Avian Reovirus p17 through Inhibition of CDK1 and Plk1 Impacting the G2/M Phase of the Cell Cycle.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27603133","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15337701","id":"PMC_15337701","title":"Homozygous deficiency of heparin cofactor II: relevance of P17 glutamate residue in serpins, relationship with conformational diseases, and role in thrombosis.","date":"2004","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/15337701","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14527342","id":"PMC_14527342","title":"Cross-reactivity between HLA-A2-restricted FLU-M1:58-66 and HIV p17 GAG:77-85 epitopes in HIV-infected and uninfected individuals.","date":"2003","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/14527342","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25704763","id":"PMC_25704763","title":"A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV setting.","date":"2015","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25704763","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28871125","id":"PMC_28871125","title":"HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28871125","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12542496","id":"PMC_12542496","title":"HIV-1 matrix protein p17 enhances the proliferative activity of natural killer cells and increases their ability to secrete proinflammatory cytokines.","date":"2003","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/12542496","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27799525","id":"PMC_27799525","title":"Expression of HIV-1 matrix protein p17 and association with B-cell lymphoma in HIV-1 transgenic mice.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/27799525","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23741494","id":"PMC_23741494","title":"Transforming growth factor-beta inhibition reduces progression of early choroidal neovascularization lesions in rats: P17 and P144 peptides.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23741494","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21849287","id":"PMC_21849287","title":"Fine epitope specificity of anti-erythropoietin antibodies reveals molecular mimicry with HIV-1 p17 protein: a pathogenetic mechanism for HIV-1-related anemia.","date":"2011","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/21849287","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19755123","id":"PMC_19755123","title":"Identification and characterisation of the novel amyloid-beta peptide-induced protein p17.","date":"2009","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/19755123","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2902864","id":"PMC_2902864","title":"Follow-up of subjects with isolated and persistent anti-core (anti-p24 or anti-p17) antibodies to HIV.","date":"1988","source":"AIDS (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/2902864","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1690277","id":"PMC_1690277","title":"Immune response and epitope mapping of a candidate HIV-1 p17 vaccine HGP30.","date":"1990","source":"Journal of clinical laboratory analysis","url":"https://pubmed.ncbi.nlm.nih.gov/1690277","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12009290","id":"PMC_12009290","title":"Long-term follow-up: no effect of therapeutic vaccination with HIV-1 p17/p24:Ty virus-like particles on HIV-1 disease progression.","date":"2002","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/12009290","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8659115","id":"PMC_8659115","title":"Evidence for direct association of Vpr and matrix protein p17 within the HIV-1 virion.","date":"1996","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/8659115","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24456624","id":"PMC_24456624","title":"Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study.","date":"2014","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/24456624","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23166320","id":"PMC_23166320","title":"Molecular interaction studies of HIV-1 matrix protein p17 and heparin: identification of the heparin-binding motif of p17 as a target for the development of multitarget antagonists.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23166320","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1823903","id":"PMC_1823903","title":"Preclinical and clinical studies on immunogenicity and safety of the HIV-1 p17-based synthetic peptide AIDS vaccine--HGP-30-KLH.","date":"1991","source":"International journal of immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/1823903","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9517986","id":"PMC_9517986","title":"HIV p17 enhances lymphocyte proliferation and HIV-1 replication after binding to a human serum factor.","date":"1998","source":"AIDS (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9517986","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16709828","id":"PMC_16709828","title":"Degeneracy and repertoire of the human HIV-1 Gag p17(77-85) CTL response.","date":"2006","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16709828","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31375578","id":"PMC_31375578","title":"Heterogeneous Nuclear Ribonucleoprotein A1 and Lamin A/C Modulate Nucleocytoplasmic Shuttling of Avian Reovirus p17.","date":"2019","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/31375578","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7909231","id":"PMC_7909231","title":"A 7-year analysis of anti-Gag (p17 and p24) antibodies in HIV-1-seropositive patients with haemophilia: immunoglobulin G titre and avidity are early predictors of clinical course.","date":"1993","source":"AIDS (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/7909231","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16713032","id":"PMC_16713032","title":"The HIV-1 matrix protein p17 can be efficiently delivered by intranasal route in mice using the TLR 2/6 agonist MALP-2 as mucosal adjuvant.","date":"2005","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/16713032","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12576096","id":"PMC_12576096","title":"Substance P(1-7) affects the expression of dopamine D2 receptor mRNA in male rat brain during morphine withdrawal.","date":"2003","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/12576096","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30248376","id":"PMC_30248376","title":"Identification of amino acid residues critical for the B cell growth-promoting activity of HIV-1 matrix protein p17 variants.","date":"2018","source":"Biochimica et biophysica acta. General subjects","url":"https://pubmed.ncbi.nlm.nih.gov/30248376","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18602957","id":"PMC_18602957","title":"Synthetic peptide AT20 coupled to KLH elicits antibodies against a conserved conformational epitope from a major functional area of the HIV-1 matrix protein p17.","date":"2008","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/18602957","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15386266","id":"PMC_15386266","title":"Preclinical studies on immunogenicity of the HIV-1 p17-based synthetic peptide AT20-KLH.","date":"2004","source":"Biopolymers","url":"https://pubmed.ncbi.nlm.nih.gov/15386266","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1692727","id":"PMC_1692727","title":"Prevalence of antibodies to the core protein P17, a serological marker during HIV-1 infection.","date":"1990","source":"AIDS research and human retroviruses","url":"https://pubmed.ncbi.nlm.nih.gov/1692727","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9725267","id":"PMC_9725267","title":"cDNA encoding a single-chain antibody to HIV p17 with cytoplasmic or nuclear retention signals inhibits HIV-1 replication.","date":"1998","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9725267","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12763761","id":"PMC_12763761","title":"The p17 cleaved form of caspase-3 is present within viable macrophages in vitro and in atherosclerotic plaque.","date":"2003","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12763761","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1457192","id":"PMC_1457192","title":"HIV-1 matrix protein p17 resides in cell nuclei in association with genomic RNA.","date":"1992","source":"AIDS research and human retroviruses","url":"https://pubmed.ncbi.nlm.nih.gov/1457192","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7498281","id":"PMC_7498281","title":"Substance P-(1-7) and substance P-(5-11) locally modulate dopamine release in rat striatum.","date":"1995","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/7498281","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21810978","id":"PMC_21810978","title":"Transforming growth factor-β inhibition decreases diode laser-induced choroidal neovascularization development in rats: P17 and P144 peptides.","date":"2011","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/21810978","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20850858","id":"PMC_20850858","title":"HIV-1 Gag p17 presented as virus-like particles on the E2 scaffold from Geobacillus stearothermophilus induces sustained humoral and cellular immune responses in the absence of IFNγ production by CD4+ T cells.","date":"2010","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/20850858","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28747658","id":"PMC_28747658","title":"A single amino acid substitution confers B-cell clonogenic activity to the HIV-1 matrix protein p17.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28747658","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23900679","id":"PMC_23900679","title":"The protein p17 signaling pathways in cancer.","date":"2013","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23900679","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1376412","id":"PMC_1376412","title":"Clonal analysis of murine B cell response to the human immunodeficiency virus type 1 (HIV1)-gag p17 and p25 antigens.","date":"1992","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1376412","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8573375","id":"PMC_8573375","title":"The genetic diversification of the HIV type 1 gag p17 gene in patients infected from a common source.","date":"1995","source":"AIDS research and human retroviruses","url":"https://pubmed.ncbi.nlm.nih.gov/8573375","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9075480","id":"PMC_9075480","title":"Gag-specific immune responses after immunization with p17/p24:Ty virus-like particles in HIV type 1-seropositive individuals.","date":"1997","source":"AIDS research and human retroviruses","url":"https://pubmed.ncbi.nlm.nih.gov/9075480","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36680090","id":"PMC_36680090","title":"The Indirect ELISA and Monoclonal Antibody against African Swine Fever Virus p17 Revealed Efficient Detection and Application Prospects.","date":"2022","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/36680090","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27905556","id":"PMC_27905556","title":"Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27905556","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10408724","id":"PMC_10408724","title":"Characterization of mother-infant HIV type 1 gag p17 sequences associated with perinatal transmission.","date":"1999","source":"AIDS research and human retroviruses","url":"https://pubmed.ncbi.nlm.nih.gov/10408724","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1372353","id":"PMC_1372353","title":"Specific antibody responses to synthetic peptides of HIV-1 p17 correlate with different stages of HIV-1 infection.","date":"1992","source":"Journal of acquired immune deficiency syndromes","url":"https://pubmed.ncbi.nlm.nih.gov/1372353","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22749061","id":"PMC_22749061","title":"The HIV-1 major splice donor D1 is activated by splicing enhancer elements within the leader region and the p17-inhibitory sequence.","date":"2012","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/22749061","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1466950","id":"PMC_1466950","title":"A phase I study of HGP-30, a 30 amino acid subunit of the human immunodeficiency virus (HIV) p17 synthetic peptide analogue sub-unit vaccine in seronegative subjects.","date":"1992","source":"AIDS research and human retroviruses","url":"https://pubmed.ncbi.nlm.nih.gov/1466950","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34111449","id":"PMC_34111449","title":"P17 induces chemotaxis and differentiation of monocytes via MRGPRX2-mediated mast cell-line activation.","date":"2021","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34111449","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15839410","id":"PMC_15839410","title":"Sequence and phylogenetic analysis of P10- and P17-encoding genes of avian reovirus.","date":"2005","source":"Avian diseases","url":"https://pubmed.ncbi.nlm.nih.gov/15839410","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28592537","id":"PMC_28592537","title":"Role of Autophagy in HIV-1 Matrix Protein p17-Driven Lymphangiogenesis.","date":"2017","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/28592537","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8370162","id":"PMC_8370162","title":"A longitudinal study of the IgG antibody response to HIV-1 p17 gag protein in HIV-1+ patients with haemophilia: titre and avidity.","date":"1993","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8370162","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37442088","id":"PMC_37442088","title":"African swine fever virus protein p17 promotes mitophagy by facilitating the interaction of SQSTM1 with TOMM70.","date":"2023","source":"Virulence","url":"https://pubmed.ncbi.nlm.nih.gov/37442088","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8676472","id":"PMC_8676472","title":"Characterization of human immunodeficiency virus type 1 p17 matrix protein motifs associated with mother-to-child transmission.","date":"1996","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/8676472","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2064827","id":"PMC_2064827","title":"p17 and p17-containing gag precursors of input human immunodeficiency virus are transported into the nuclei of infected cells.","date":"1991","source":"AIDS research and human retroviruses","url":"https://pubmed.ncbi.nlm.nih.gov/2064827","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21693026","id":"PMC_21693026","title":"Platelet factor-4 and its p17-70 peptide inhibit myeloma proliferation and angiogenesis in vivo.","date":"2011","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21693026","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8919996","id":"PMC_8919996","title":"Identification and characterization of Schistosoma mansoni p17.7, a cyclophilin.","date":"1996","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/8919996","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26302809","id":"PMC_26302809","title":"HIV-1 Matrix Protein p17 and its Receptors.","date":"2016","source":"Current drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/26302809","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26333571","id":"PMC_26333571","title":"Angiogenic, lymphangiogenic and adipogenic effects of HIV-1 matrix protein p17.","date":"2015","source":"Pathogens and disease","url":"https://pubmed.ncbi.nlm.nih.gov/26333571","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25234718","id":"PMC_25234718","title":"Lead discovery and in silico 3D structure modeling of tumorigenic FAM72A (p17).","date":"2014","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25234718","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35107368","id":"PMC_35107368","title":"p17-Modulated Hsp90/Cdc37 Complex Governs Oncolytic Avian Reovirus Replication by Chaperoning p17, Which Promotes Viral Protein Synthesis and Accumulation of Viral Proteins σC and σA in Viral Factories.","date":"2022","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/35107368","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2514776","id":"PMC_2514776","title":"Interferon-gamma is associated with the surface of the human immunodeficiency virus and binds to the gag gene product p17.","date":"1989","source":"AIDS research and human retroviruses","url":"https://pubmed.ncbi.nlm.nih.gov/2514776","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11000277","id":"PMC_11000277","title":"Cloning and characterization of the histone-fold proteins YBL1 and YCL1.","date":"2000","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/11000277","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33093643","id":"PMC_33093643","title":"B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation.","date":"2020","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33093643","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9858710","id":"PMC_9858710","title":"Bacteriophage phi29 early protein p17 is conditionally required for the first rounds of viral DNA replication.","date":"1998","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/9858710","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32370293","id":"PMC_32370293","title":"Encapsulating TGF-β1 Inhibitory Peptides P17 and P144 as a Promising Strategy to Facilitate Their Dissolution and to Improve Their Functionalization.","date":"2020","source":"Pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/32370293","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12009292","id":"PMC_12009292","title":"Flt3 ligand and conjugation to IL-1beta peptide as adjuvants for a type 1, T-cell response to an HIV p17 gag vaccine.","date":"2002","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/12009292","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18553937","id":"PMC_18553937","title":"Solution X-ray scattering reveals a novel structure of calmodulin complexed with a binding domain peptide from the HIV-1 matrix protein p17.","date":"2008","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18553937","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31673058","id":"PMC_31673058","title":"Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31673058","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32553171","id":"PMC_32553171","title":"Lymphocyte-Specific Function of the DNA Polymerase Epsilon Subunit Pole3 Revealed by Neomorphic Alleles.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32553171","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11535326","id":"PMC_11535326","title":"Induction of cross clade reactive specific antibodies in mice by conjugates of HGP-30 (peptide analog of HIV-1(SF2) p17) and peptide segments of human beta-2-microglobulin or MHC II beta chain.","date":"2001","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/11535326","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2120806","id":"PMC_2120806","title":"Failure to detect evidence of human immunodeficiency virus type 1 (HIV-1) infection by polymerase chain reaction assay in blood donors with isolated core antibodies (anti-p24 or -p17) to HIV-1.","date":"1990","source":"Transfusion","url":"https://pubmed.ncbi.nlm.nih.gov/2120806","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17081983","id":"PMC_17081983","title":"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17081983","citation_count":2861,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16189514","id":"PMC_16189514","title":"Towards a proteome-scale map of the human protein-protein interaction network.","date":"2005","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/16189514","citation_count":2090,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22658674","id":"PMC_22658674","title":"Insights into RNA biology from an atlas of mammalian mRNA-binding proteins.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22658674","citation_count":1718,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22190034","id":"PMC_22190034","title":"Global landscape of HIV-human protein complexes.","date":"2011","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/22190034","citation_count":593,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28319085","id":"PMC_28319085","title":"Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions.","date":"2017","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/28319085","citation_count":378,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22863883","id":"PMC_22863883","title":"A high-throughput approach for measuring temporal changes in the interactome.","date":"2012","source":"Nature methods","url":"https://pubmed.ncbi.nlm.nih.gov/22863883","citation_count":273,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12434153","id":"PMC_12434153","title":"An ACF1-ISWI chromatin-remodeling complex is required for DNA replication through heterochromatin.","date":"2002","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12434153","citation_count":250,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21516116","id":"PMC_21516116","title":"Next-generation sequencing to generate interactome datasets.","date":"2011","source":"Nature methods","url":"https://pubmed.ncbi.nlm.nih.gov/21516116","citation_count":200,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10880450","id":"PMC_10880450","title":"HuCHRAC, a human ISWI chromatin remodelling complex contains hACF1 and two novel histone-fold proteins.","date":"2000","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10880450","citation_count":184,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18838386","id":"PMC_18838386","title":"Human ATAC Is a GCN5/PCAF-containing acetylase complex with a novel NC2-like histone fold module that interacts with the TATA-binding protein.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18838386","citation_count":176,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21172662","id":"PMC_21172662","title":"The ACF1 complex is required for DNA double-strand break repair in human cells.","date":"2010","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/21172662","citation_count":170,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30804502","id":"PMC_30804502","title":"H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.","date":"2019","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/30804502","citation_count":162,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32416067","id":"PMC_32416067","title":"Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.","date":"2020","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/32416067","citation_count":159,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21832049","id":"PMC_21832049","title":"Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21832049","citation_count":131,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32694731","id":"PMC_32694731","title":"Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.","date":"2020","source":"Nature metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/32694731","citation_count":92,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29229926","id":"PMC_29229926","title":"Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29229926","citation_count":89,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15164053","id":"PMC_15164053","title":"DNA sequence and analysis of human chromosome 9.","date":"2004","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/15164053","citation_count":86,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48039,"output_tokens":933,"usd":0.079056},"stage2":{"model":"claude-opus-4-6","input_tokens":4118,"output_tokens":1522,"usd":0.08796},"total_usd":0.388362,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":60074,"output_tokens":2308,"usd":0.107421},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":5170,"output_tokens":2004,"usd":0.113925}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2018,\n      \"finding\": \"POLE3-POLE4 subcomplex of the leading-strand polymerase Polε selectively binds histones H3-H4 and functions as a histone chaperone that promotes tetrasome formation and DNA supercoiling in vitro. In cells, POLE3-POLE4 binds both newly synthesized and parental histones, and its depletion hinders helicase unwinding, chromatin PCNA unloading, and compromises coordinated parental histone retention and new histone deposition at the replication fork.\",\n      \"method\": \"Hydrogen/deuterium exchange mass spectrometry, physical domain mapping, biochemical reconstitution (tetrasome formation and DNA supercoiling assays), co-immunoprecipitation of newly synthesized and parental histones, cellular depletion with defined phenotypic readouts\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reconstitution in vitro + multiple orthogonal methods + functional cellular validation in a single study\",\n      \"pmids\": [\"30217558\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"POLE3 (one of four components of the POLE holoenzyme) harbors a histone fold domain and a unique acidic C-terminus; mice lacking Pole3 survive only to late embryonic stages, indicating it is dispensable for bulk DNA replication but required for normal T and B cell development. Neomorphic alleles with gradually increasing positive charges in the acidic C-terminus cause progressive peripheral lymphopenia, revealing a stage-specific, non-replicative function of the histone fold domain of POLE3 during lymphocyte development.\",\n      \"method\": \"Mouse knockout and hypomorphic/neomorphic allele generation; flow cytometry of lymphocyte populations; genetic epistasis analysis of domain-specific mutations\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO and allelic series with defined cellular phenotypes; replicated across multiple alleles in same study\",\n      \"pmids\": [\"32553171\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"YBL1 (POLE3 ortholog) and YCL1, members of the H2A-H2B histone fold sub-family, have no intrinsic CCAAT- or TATA-binding capacity but can form complexes with histones in solution and on DNA in nucleosome reconstitution assays, and are part of relatively large complexes as determined by glycerol gradient sedimentation.\",\n      \"method\": \"Nucleosome reconstitution assay, glycerol gradient sedimentation, sequence/structural analysis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro reconstitution with histones; single study but multiple methods\",\n      \"pmids\": [\"11000277\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"POLE3 is an accessory subunit of the DNA polymerase epsilon (POLE) holoenzyme that, together with POLE4, forms an H3-H4 histone chaperone complex that selectively binds both newly synthesized and parental histones at the replication fork, promotes tetrasome formation and DNA supercoiling in vitro, facilitates faithful nucleosome dynamics (parental histone recycling and new histone deposition) during DNA replication, and additionally performs a non-replicative, cell-type-specific function through its histone fold domain that is required for normal T and B lymphocyte development.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nLooking at the corpus, I need to identify papers about the canonical POLE3 protein (a subunit of DNA polymerase epsilon with a histone fold domain, involved in DNA replication and chromatin assembly).\n\n**Classification:**\n\nFrom the retrieved papers:\n- Paper [4] (PMID:30217558): KEEP — directly about POLE3-POLE4 as histone chaperone\n- Paper [98] (PMID:32553171): KEEP — directly about Pole3 in lymphocyte development\n- Paper [91] (PMID:11000277): KEEP — about YBL1/YCL1 which are POLE3/POLE4 homologs (H2A-H2B subfamily histone fold proteins in nucleosome reconstitution)\n- All other retrieved papers: EXCLUDE (HIV p17, caspase p17, avian reovirus p17, ASFV p17, various p17 peptides — all alias collisions)\n\nFrom gene2pubmed papers:\n- Paper [23] (PMID:18838386): KEEP — identifies POLE3/CHRAC17 in human ATAC complex\n- Paper [22] (PMID:10880450): KEEP — HuCHRAC contains histone-fold proteins (POLE3/POLE4 orthologs)\n- Paper [24] (PMID:21172662): KEEP — ACF1/CHRAC complex (contains CHRAC15/CHRAC17 = POLE4/POLE3) in DSB repair\n- Paper [20] (PMID:12434153): KEEP — ACF1-ISWI complex with CHRAC subunits in heterochromatin replication\n- Paper [25] (PMID:30804502): KEEP — mentions new histones/H4K20me0, tangentially; actually about BRCA1-BARD1 — marginal\n- Paper [1] (PMID:17081983): EXCLUDE — general phosphoproteomics, POLE3 not specifically studied\n- Papers [2,3,5,6,7,8,10,11,12,13,15,19,21]: EXCLUDE — large interactome/proteome maps, no specific POLE3 mechanistic findings\n- Papers [4,9,14,16,17]: EXCLUDE — cDNA/genome sequencing projects\n- Papers [18,26,28,29]: EXCLUDE — CRISPR screens, no POLE3-specific mechanistic data\n- Paper [27]: EXCLUDE — TPPP/p25, unrelated\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"POLE3 (CHRAC17) and POLE4 (CHRAC15) are two novel histone-fold proteins present in the human CHRAC (HuCHRAC) chromatin-remodeling complex alongside hACF1 and SNF2H (ISWI). The two histone-fold proteins form a stable sub-complex that binds naked DNA but not nucleosomes.\",\n      \"method\": \"Biochemical purification of HuCHRAC, identification of subunits, in vitro DNA-binding assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct biochemical purification and characterization of complex with functional binding assays\",\n      \"pmids\": [\"10880450\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The ACF1-ISWI chromatin-remodeling complex (which contains POLE3/CHRAC17 and POLE4/CHRAC15 as subunits) is specifically required for DNA replication through pericentromeric heterochromatin; RNAi depletion of ACF1 impairs late-S-phase replication of heterochromatic regions.\",\n      \"method\": \"RNAi depletion, BrdU incorporation, cell-cycle analysis, immunofluorescence showing enrichment at replicating heterochromatin\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional KD with specific heterochromatin replication phenotype, orthogonal methods\",\n      \"pmids\": [\"12434153\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"POLE3 (CHRAC17) and POLE4 are components of the human ATAC acetyltransferase complex, associating with GCN5/PCAF acetyltransferases and other chromatin-regulatory factors, linking the POLE complex subunits to transcriptional regulation in addition to DNA replication.\",\n      \"method\": \"Biochemical purification of human ATAC complex followed by mass spectrometry and co-immunoprecipitation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct purification of complex with mass spectrometry and reciprocal co-IP validation\",\n      \"pmids\": [\"18838386\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The CHRAC complex (containing ACF1, SNF2H, CHRAC15/POLE4, and CHRAC17/POLE3) accumulates rapidly at DNA double-strand breaks (DSBs) and is required for DSB repair via both NHEJ and HR. ACF1 interacts directly with KU70 and is required for KU70/80 accumulation at DSBs; depletion of ACF1 or SNF2H causes extreme sensitivity to DSB-inducing agents and failure to repair DSBs.\",\n      \"method\": \"Live-cell imaging of GFP-tagged subunits at laser-induced DSBs, co-immunoprecipitation, RNAi depletion, clonogenic survival, DSB repair reporter assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (live imaging, co-IP, KD + functional readouts) in a single study\",\n      \"pmids\": [\"21172662\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The POLE3-POLE4 subcomplex of DNA polymerase epsilon selectively binds histones H3-H4 (not H2A-H2B) through defined minimal domains identified by hydrogen/deuterium exchange mass spectrometry. POLE3-POLE4 acts as a bona fide histone chaperone, promoting tetrasome formation and DNA supercoiling in vitro. In cells, POLE3-POLE4 associates with both newly synthesized and parental histones; its depletion impairs replication fork helicase unwinding, delays chromatin PCNA unloading, and disrupts coordinated parental histone retention and new histone deposition, demonstrating a role in replication-coupled nucleosome assembly.\",\n      \"method\": \"Hydrogen/deuterium exchange mass spectrometry, pulldown/co-IP mapping of interaction domains, in vitro tetrasome formation and DNA supercoiling assays, iPOND (isolation of proteins on nascent DNA), flow cytometry, proximity ligation assay\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted histone chaperone activity in vitro plus multiple orthogonal cellular assays; single rigorous study with strong mechanistic resolution\",\n      \"pmids\": [\"30217558\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In mice, Pole3 is dispensable for bulk DNA replication (null mice survive to late embryonic stages) but is required in a stage-specific manner during T and B lymphocyte development. The histone fold domain of POLE3 mediates this lymphocyte-specific function. Progressive introduction of positively charged residues into the normally acidic C-terminus of POLE3 causes increasingly severe peripheral lymphopenia, revealing that the acidic C-terminus is functionally critical for lymphocyte homeostasis.\",\n      \"method\": \"Mouse knockout and hypomorphic/neomorphic allele generation, flow cytometric analysis of lymphocyte development stages, domain-specific mutagenesis of the acidic C-terminus\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple defined alleles with graded phenotypic consequences, clean developmental stage mapping\",\n      \"pmids\": [\"32553171\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"POLE3, together with its obligate partner POLE4, forms a histone H3-H4 chaperone subcomplex within the DNA polymerase epsilon holoenzyme that promotes tetrasome formation and replication-coupled nucleosome assembly at the replication fork; it is also a structural component of the CHRAC chromatin-remodeling complex (with ACF1/SNF2H) required for heterochromatin replication and DNA double-strand break repair, and participates in the ATAC acetyltransferase complex, while its histone fold domain and acidic C-terminus confer non-replicative, lymphocyte-specific functions during T and B cell development in vivo.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"POLE3 is an accessory subunit of the DNA polymerase epsilon (Polε) holoenzyme that, together with POLE4, functions as a histone H3-H4 chaperone at the replication fork. The POLE3-POLE4 subcomplex contains histone fold domains, selectively binds both newly synthesized and parental histones H3-H4, and promotes tetrasome formation and DNA supercoiling in vitro; in cells, its depletion impairs helicase unwinding, chromatin PCNA unloading, and coordinated parental histone recycling and new histone deposition during replication [PMID:30217558, PMID:11000277]. Beyond its replicative role, POLE3 possesses a unique acidic C-terminus whose charge is critical for a non-replicative, cell-type-specific function: mice lacking Pole3 die in late embryogenesis, and neomorphic alleles with progressively altered C-terminal charge cause stage-specific defects in T and B lymphocyte development, revealing a separable developmental role for the histone fold domain [PMID:32553171].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Whether the histone-fold-containing subunit of Polε (YBL1/POLE3) could interact with histones was unknown; reconstitution experiments showed it forms complexes with histones in solution and on DNA, establishing it as a histone-fold protein capable of direct histone association.\",\n      \"evidence\": \"Nucleosome reconstitution assay and glycerol gradient sedimentation with recombinant yeast YBL1 (POLE3 ortholog)\",\n      \"pmids\": [\"11000277\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single study without independent confirmation in mammalian systems\",\n        \"Selectivity for specific histone pairs (H3-H4 vs. H2A-H2B) not resolved\",\n        \"No functional consequence of histone binding was demonstrated\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Whether POLE3-POLE4 acts as a bona fide histone chaperone at the replication fork was unresolved; biochemical reconstitution and cellular depletion established that the subcomplex selectively binds H3-H4, promotes tetrasome formation, and is required for coordinated parental histone recycling and new histone deposition during replication.\",\n      \"evidence\": \"HDX-MS domain mapping, in vitro tetrasome formation and DNA supercoiling assays, co-immunoprecipitation of newly synthesized and parental histones, cellular depletion with functional readouts in human cells\",\n      \"pmids\": [\"30217558\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of H3-H4 recognition by POLE3-POLE4 not determined\",\n        \"Relative contribution of POLE3 versus POLE4 to chaperone activity not dissected\",\n        \"How POLE3-POLE4 chaperone activity is coordinated with CAF-1 and other fork-associated chaperones remains unclear\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Whether POLE3 has functions beyond DNA replication was unknown; a mouse allelic series revealed that POLE3 is essential for embryonic viability and that its histone fold domain and acidic C-terminus perform a separable, non-replicative role required for T and B lymphocyte development.\",\n      \"evidence\": \"Mouse knockout and neomorphic allele series with charge-altered C-termini; flow cytometry of lymphocyte populations and genetic epistasis analysis\",\n      \"pmids\": [\"32553171\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Molecular target(s) of the POLE3 histone fold domain in lymphocytes not identified\",\n        \"Whether the lymphocyte phenotype reflects a chromatin remodeling or signaling function is unknown\",\n        \"Whether POLE4 is required for the non-replicative lymphocyte function of POLE3 is untested\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis of POLE3-POLE4 histone chaperone activity, the identity of its non-replicative binding partners in lymphocytes, and how its dual replicative and developmental functions are coordinated remain open questions.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No high-resolution structure of the POLE3-POLE4-H3-H4 complex\",\n        \"Mechanism by which POLE3 acidic C-terminal charge regulates lymphocyte development is uncharacterized\",\n        \"Functional interplay between POLE3-POLE4 chaperone activity and other replication-coupled histone chaperones (e.g., CAF-1, MCM2) not resolved\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [0, 2]},\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"R-HSA-69306\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"complexes\": [\n      \"DNA polymerase epsilon (Polε)\"\n    ],\n    \"partners\": [\n      \"POLE4\",\n      \"H3\",\n      \"H4\",\n      \"PCNA\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"POLE3 is a histone-fold protein that, together with its obligate partner POLE4, serves as a histone H3–H4 chaperone subcomplex within the DNA polymerase epsilon holoenzyme, promoting tetrasome formation and replication-coupled nucleosome assembly at the replication fork [PMID:30217558]. Beyond its replicative role, POLE3 is a structural subunit of the CHRAC chromatin-remodeling complex (with ACF1 and SNF2H), which is required for heterochromatin replication in late S-phase and for DNA double-strand break repair via both NHEJ and HR [PMID:10880450, PMID:12434153, PMID:21172662], and is also a component of the ATAC acetyltransferase complex [PMID:18838386]. In mice, Pole3 is dispensable for bulk DNA replication but is specifically required during T and B lymphocyte development, where its histone fold domain and acidic C-terminus are functionally critical for lymphocyte homeostasis [PMID:32553171].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Identification of POLE3 as a histone-fold subunit of the CHRAC chromatin-remodeling complex established that this small protein participates in chromatin architecture beyond its association with DNA polymerase epsilon.\",\n      \"evidence\": \"Biochemical purification of HuCHRAC and in vitro DNA-binding assays showing POLE3–POLE4 heterodimer binds naked DNA\",\n      \"pmids\": [\"10880450\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the POLE3–POLE4 DNA-binding activity is functionally required within CHRAC was not resolved\",\n        \"No information on POLE3 function independent of the CHRAC complex\"\n      ]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Demonstrating that the ACF1–ISWI/CHRAC complex is specifically needed for heterochromatin replication in late S-phase placed POLE3 in the context of replication through difficult chromatin templates.\",\n      \"evidence\": \"RNAi depletion of ACF1 combined with BrdU incorporation, cell-cycle analysis, and immunofluorescence in human cells\",\n      \"pmids\": [\"12434153\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"POLE3 was not individually depleted; phenotype attributed to the whole CHRAC/ACF complex\",\n        \"Mechanism by which CHRAC facilitates heterochromatin replication (remodeling vs. histone chaperoning) was unresolved\"\n      ]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Finding POLE3 and POLE4 within the ATAC acetyltransferase complex expanded their functional repertoire to transcriptional regulation via histone acetylation.\",\n      \"evidence\": \"Biochemical purification of the human ATAC complex with mass spectrometry and reciprocal co-immunoprecipitation\",\n      \"pmids\": [\"18838386\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Functional contribution of POLE3–POLE4 within the ATAC complex was not tested\",\n        \"Whether POLE3 participates in ATAC and Pol epsilon simultaneously or in mutually exclusive pools was unknown\"\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Showing that the CHRAC complex rapidly accumulates at DNA double-strand breaks and is required for both NHEJ and HR revealed a DNA repair function for POLE3-containing chromatin remodeling machinery.\",\n      \"evidence\": \"Live-cell imaging of GFP-tagged subunits at laser-induced DSBs, co-immunoprecipitation with KU70, RNAi depletion combined with clonogenic survival and DSB repair reporter assays\",\n      \"pmids\": [\"21172662\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct requirement for POLE3 specifically (as opposed to other CHRAC subunits) at DSBs was not isolated\",\n        \"Whether the histone-fold DNA-binding activity of POLE3–POLE4 contributes to CHRAC recruitment at DSBs was untested\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Reconstituting POLE3–POLE4 as a bona fide H3–H4 histone chaperone that promotes tetrasome assembly resolved the long-standing question of how the Pol epsilon holoenzyme participates in replication-coupled nucleosome assembly.\",\n      \"evidence\": \"HDX-MS domain mapping, in vitro tetrasome and supercoiling assays, iPOND, flow cytometry, and proximity ligation assay in human cells\",\n      \"pmids\": [\"30217558\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of H3–H4 recognition by the POLE3–POLE4 heterodimer at atomic resolution was not determined\",\n        \"Relative contributions of POLE3–POLE4 vs. other chaperones (e.g., CAF-1, ASF1) at the fork were not quantified\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Mouse genetics demonstrated that POLE3 is dispensable for bulk DNA replication but essential for lymphocyte development, establishing a non-replicative, tissue-specific function mediated by its histone fold and acidic C-terminus.\",\n      \"evidence\": \"Pole3 knockout and charge-reversal allele series in mice with flow cytometric staging of T and B cell development\",\n      \"pmids\": [\"32553171\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Molecular mechanism linking POLE3 histone-fold and acidic tail to lymphocyte-specific chromatin regulation is unknown\",\n        \"Whether the lymphocyte phenotype reflects disrupted histone chaperoning, CHRAC function, ATAC activity, or a distinct interaction is unresolved\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"An atomic-resolution structure of POLE3–POLE4 bound to H3–H4 is lacking, and the mechanistic basis of the lymphocyte-specific requirement remains uncharacterized.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No high-resolution structure of the POLE3–POLE4–H3–H4 complex\",\n        \"Functional partitioning of POLE3 among Pol epsilon, CHRAC, and ATAC pools in vivo is undetermined\",\n        \"Molecular basis of the tissue-specific (lymphocyte) requirement for POLE3 is unknown\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [1, 4]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-69306\", \"supporting_discovery_ids\": [1, 4]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [0, 4]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"complexes\": [\n      \"DNA polymerase epsilon\",\n      \"CHRAC\",\n      \"ATAC\"\n    ],\n    \"partners\": [\n      \"POLE4\",\n      \"ACF1\",\n      \"SNF2H\",\n      \"KU70\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}